Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Andrade

Showing results (581-590 of 625) with videos related to

Pageof 63
Sort By:
Transplantation Proceedings|October 3, 2012
Guidelines for maintenance of adult patients with brain death and potential for multiple organ donations: the Task Force of the Brazilian Association of Intensive Medicine the Brazilian Association of Organs Transplantation, and the Transplantation Center of Santa CatarinaG A Westphal, M Caldeira Filho, A Fiorelli, et al.
Gastroenterology|February 12, 2019
Incidence and Etiology of Drug-Induced Liver Injury in Mainland ChinaTao Shen, Yingxia Liu, Jia Shang, et al.
Cell Death & Disease|February 11, 2022
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagyHui Ye, Chaobo Chen, Hanghang Wu, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Safety of hydroxyanthracene derivatives for use in food, Maged Younes, Peter Aggett, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2018
Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI RegistryInmaculada Medina-Caliz, Miren Garcia-Cortes, Andres Gonzalez-Jimenez, et al.
Scientific Reports|March 2, 2022
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulationRocío Gallego-Durán, Javier Ampuero, Helena Pastor-Ramírez, et al.
The Lancet. Gastroenterology & Hepatology|October 15, 2019
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trialElisa Pose, Laura Napoleone, Ahmed Amin, et al.
Hepatology (Baltimore, Md.)|April 8, 2022
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemiaMarta Alonso-Peña, Ricardo Espinosa-Escudero, Elisa Herraez, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 4, 2025
Defining non-invasive criteria for indicating drug therapy in metabolic-associated steatotic liver disease in clinical practiceAntonio Olveira, Javier Crespo, Luis Ibañez-Samaniego, et al.
Gastroenterology Report|January 24, 2024
Hepatitis C virus point-of-care microelimination approach in a vulnerable population in the South of SpainJosé María Pinazo-Bandera, Jesús Aranda, Alberto Manuel García-García, et al.
Pageof 63

Showing results (581-590 of 625) with videos related to

Sort By:
Pageof 63
Transplantation Proceedings|October 3, 2012
Guidelines for maintenance of adult patients with brain death and potential for multiple organ donations: the Task Force of the Brazilian Association of Intensive Medicine the Brazilian Association of Organs Transplantation, and the Transplantation Center of Santa CatarinaG A Westphal, M Caldeira Filho, A Fiorelli, et al.
Gastroenterology|February 12, 2019
Incidence and Etiology of Drug-Induced Liver Injury in Mainland ChinaTao Shen, Yingxia Liu, Jia Shang, et al.
Cell Death & Disease|February 11, 2022
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagyHui Ye, Chaobo Chen, Hanghang Wu, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Safety of hydroxyanthracene derivatives for use in food, Maged Younes, Peter Aggett, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2018
Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI RegistryInmaculada Medina-Caliz, Miren Garcia-Cortes, Andres Gonzalez-Jimenez, et al.
Scientific Reports|March 2, 2022
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulationRocío Gallego-Durán, Javier Ampuero, Helena Pastor-Ramírez, et al.
The Lancet. Gastroenterology & Hepatology|October 15, 2019
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trialElisa Pose, Laura Napoleone, Ahmed Amin, et al.
Hepatology (Baltimore, Md.)|April 8, 2022
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemiaMarta Alonso-Peña, Ricardo Espinosa-Escudero, Elisa Herraez, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 4, 2025
Defining non-invasive criteria for indicating drug therapy in metabolic-associated steatotic liver disease in clinical practiceAntonio Olveira, Javier Crespo, Luis Ibañez-Samaniego, et al.
Gastroenterology Report|January 24, 2024
Hepatitis C virus point-of-care microelimination approach in a vulnerable population in the South of SpainJosé María Pinazo-Bandera, Jesús Aranda, Alberto Manuel García-García, et al.
Pageof 63